Astrazeneca (AZN) Research & Development (2009 - 2026)
Astrazeneca's Research & Development came in at $3.89 billion for Q3 2026, up 6.3% from $3.66 billion a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Research & Development (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported Research & Development of $15.3 billion, up 1.7% year-over-year; for FY2025, it was $14.23 billion, up 4.8% from FY2024.
- Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- Going back by year, Research & Development was $13.58 billion in FY2024 (+24.2%), $10.94 billion in FY2023 (+12.0%), $9.76 billion in FY2022 (+0.3%) and $9.74 billion in FY2021 (+62.5%).
- The five-year range for quarterly Research & Development is $2.13 billion (Q1 2022) to $4.68 billion (Q4 2024).
- Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 14.4% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 52.2%), and the weakest in Q3 2022 (a decline of 31.9%).
- Business Quant data shows AZN's Research & Development at $4.05 billion (Q2 2026), $3.49 billion (Q1 2026) and $3.86 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 1.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.89 Bn |
| Jun 30, 2026 | 4.05 Bn |
| Mar 31, 2026 | 3.49 Bn |
| Dec 31, 2025 | 3.86 Bn |
| Sep 30, 2025 | 3.66 Bn |
| Jun 30, 2025 | 3.55 Bn |
| Mar 31, 2025 | 3.16 Bn |
| Dec 31, 2024 | 4.68 Bn |
| Sep 30, 2024 | 3.12 Bn |
| Jun 30, 2024 | 3.01 Bn |
| Mar 31, 2024 | 2.78 Bn |
| Dec 31, 2023 | 3.07 Bn |
| Sep 30, 2023 | 2.58 Bn |
| Jun 30, 2023 | 2.67 Bn |
| Mar 31, 2023 | 2.61 Bn |
| Dec 31, 2022 | 2.63 Bn |
| Sep 30, 2022 | 2.46 Bn |
| Jun 30, 2022 | 2.55 Bn |
| Mar 31, 2022 | 2.13 Bn |
| Dec 31, 2021 | 2.58 Bn |
API Access
Astrazeneca Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();